A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Bristol-Myers Squibb/Pfizer EEIG, against the decision of the State Institute for Drug Control from 13. 5. 2020, under the no. SUKLS215786/2013 -
The appeal is dismissed and the decision under appeal is upheld.
More information: MZCR.cz